200 related articles for article (PubMed ID: 30208302)
1. Biomarker correlates of psychotherapy outcomes in borderline personality disorder: A systematic review.
Marceau EM; Meuldijk D; Townsend ML; Solowij N; Grenyer BFS
Neurosci Biobehav Rev; 2018 Nov; 94():166-178. PubMed ID: 30208302
[TBL] [Abstract][Full Text] [Related]
2. Effects of Psychotherapy on Neuronal Correlates of Reappraisal in Female Patients With Borderline Personality Disorder.
Schmitt R; Winter D; Niedtfeld I; Herpertz SC; Schmahl C
Biol Psychiatry Cogn Neurosci Neuroimaging; 2016 Nov; 1(6):548-557. PubMed ID: 29653096
[TBL] [Abstract][Full Text] [Related]
3. Frontolimbic neural circuit changes in emotional processing and inhibitory control associated with clinical improvement following transference-focused psychotherapy in borderline personality disorder.
Perez DL; Vago DR; Pan H; Root J; Tuescher O; Fuchs BH; Leung L; Epstein J; Cain NM; Clarkin JF; Lenzenweger MF; Kernberg OF; Levy KN; Silbersweig DA; Stern E
Psychiatry Clin Neurosci; 2016 Jan; 70(1):51-61. PubMed ID: 26289141
[TBL] [Abstract][Full Text] [Related]
4. Improving treatment outcomes for borderline personality disorder: what can we learn from biomarker studies of psychotherapy?
Marceau EM; Ruocco AC; Grenyer BFS
Curr Opin Psychiatry; 2023 Jan; 36(1):67-74. PubMed ID: 36017562
[TBL] [Abstract][Full Text] [Related]
5. Structural brain abnormalities in borderline personality disorder correlate with clinical severity and predict psychotherapy response.
Sampedro F; Farrés CCI; Soler J; Elices M; Schmidt C; Corripio I; Domínguez-Clavé E; Pomarol-Clotet E; Salvador R; Pascual JC
Brain Imaging Behav; 2021 Oct; 15(5):2502-2512. PubMed ID: 33634348
[TBL] [Abstract][Full Text] [Related]
6. DNA methylation of APBA3 and MCF2 in borderline personality disorder: Potential biomarkers for response to psychotherapy.
Knoblich N; Gundel F; Brückmann C; Becker-Sadzio J; Frischholz C; Nieratschker V
Eur Neuropsychopharmacol; 2018 Feb; 28(2):252-263. PubMed ID: 29274998
[TBL] [Abstract][Full Text] [Related]
7. Neurobiological and clinical effect of metacognitive interpersonal therapy vs structured clinical model: study protocol for a randomized controlled trial.
Magni LR; Carcione A; Ferrari C; Semerari A; Riccardi I; Nicolo' G; Lanfredi M; Pedrini L; Cotelli M; Bocchio L; Pievani M; Gasparotti R; Rossi R;
BMC Psychiatry; 2019 Jun; 19(1):195. PubMed ID: 31234864
[TBL] [Abstract][Full Text] [Related]
8. Neural correlates of distraction in borderline personality disorder before and after dialectical behavior therapy.
Winter D; Niedtfeld I; Schmitt R; Bohus M; Schmahl C; Herpertz SC
Eur Arch Psychiatry Clin Neurosci; 2017 Feb; 267(1):51-62. PubMed ID: 27091455
[TBL] [Abstract][Full Text] [Related]
9. Neurobiological Mechanisms Mediating Emotion Dysregulation as Targets of Change in Borderline Personality Disorder.
Herpertz SC; Schneider I; Schmahl C; Bertsch K
Psychopathology; 2018; 51(2):96-104. PubMed ID: 29672301
[TBL] [Abstract][Full Text] [Related]
10. [Borderline personality : Alterations to brain structure and function through psychotherapy].
Schmahl C; Niedtfeld I; Herpertz SC
Nervenarzt; 2018 Nov; 89(11):1232-1236. PubMed ID: 30094483
[TBL] [Abstract][Full Text] [Related]
11. [Psychotherapy of borderline personality disorder: similarities and differences in evidence-based disorder-specific treatment approaches].
Sollberger D; Walter M
Fortschr Neurol Psychiatr; 2010 Dec; 78(12):698-708. PubMed ID: 21136338
[TBL] [Abstract][Full Text] [Related]
12. Metacognitive interpersonal therapy in borderline personality disorder: Clinical and neuroimaging outcomes from the CLIMAMITHE study-A randomized clinical trial.
Rossi R; Corbo D; Magni LR; Pievani M; Nicolò G; Semerari A; Quattrini G; Riccardi I; Colle L; Conti L; Gasparotti R; Macis A; Ferrari C; Carcione A;
Personal Disord; 2023 Jul; 14(4):452-466. PubMed ID: 37227866
[TBL] [Abstract][Full Text] [Related]
13. The Neuropsychological Mechanisms of Treatment of Bipolar Disorder and Borderline Personality Disorder: Activation Likelihood Estimation Meta-Analysis of Brain Imaging Research.
Luo J; Liang M; Yi P; Li X
J Clin Psychiatry; 2023 Mar; 84(3):. PubMed ID: 36988478
[No Abstract] [Full Text] [Related]
14. [Functional Neuroimaging Pilot Study of Borderline Personality Disorder in Adolescents].
LeBoeuf A; Guilé JM; Labelle R; Luck D
Sante Ment Que; 2016; 41(1):141-62. PubMed ID: 27570955
[TBL] [Abstract][Full Text] [Related]
15. Effect of Psychotherapy for Borderline Personality Disorder on Quality of Life: A Systematic Review and Meta-Analysis.
Chakhssi F; Zoet JM; Oostendorp JM; Noordzij ML; Sommers-Spijkerman M
J Pers Disord; 2021 Apr; 35(2):255-269. PubMed ID: 31609187
[TBL] [Abstract][Full Text] [Related]
16. Psychological therapies for people with borderline personality disorder.
Binks CA; Fenton M; McCarthy L; Lee T; Adams CE; Duggan C
Cochrane Database Syst Rev; 2006 Jan; (1):CD005652. PubMed ID: 16437534
[TBL] [Abstract][Full Text] [Related]
17. Psychotherapy for Borderline Personality Disorder: Progress and Remaining Challenges.
Links PS; Shah R; Eynan R
Curr Psychiatry Rep; 2017 Mar; 19(3):16. PubMed ID: 28271272
[TBL] [Abstract][Full Text] [Related]
18. A systematic review of the neurobiological underpinnings of borderline personality disorder (BPD) in childhood and adolescence.
Winsper C; Marwaha S; Lereya ST; Thompson A; Eyden J; Singh SP
Rev Neurosci; 2016 Dec; 27(8):827-847. PubMed ID: 27518904
[TBL] [Abstract][Full Text] [Related]
19. Impulsivity and its Therapeutic Management in Borderline Personality Disorder: a Systematic Review.
Mungo A; Hein M; Hubain P; Loas G; Fontaine P
Psychiatr Q; 2020 Dec; 91(4):1333-1362. PubMed ID: 32989635
[TBL] [Abstract][Full Text] [Related]
20. [Neural mechanisms of dissociation: implication for borderline personality disorder].
Krause-Utz AD; Elzinga BM
Tijdschr Psychiatr; 2019; 61(4):267-275. PubMed ID: 31017285
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
